Trilliant Health

Between 2018 and 2024, the share of #behavioralhealth patients prescribed medications from three or more drug classes increased from 8.9% to 10.9% – with the most pronounced growth among adults ages 18-44. #Stimulant use among patients on two or more behavioral health drug classes grew faster than any other class over the study period, increasing from 22.4% to 29.3%. More in our latest study 🔗 https://lnkd.in/etb8EgZy

Despite decades of clinical investment and policy focus, women's health in the U.S. remains underserved and underprioritized. Our 2026 Women's Health Report examines 7 critical trends reshaping access, delivery and investment. Read the full report 🔗 https://lnkd.in/eBpKuz94

For decades, declining smoking rates represented one of public health's clearest successes, resulting from regulatory interventions, litigation, cultural shifts, public health campaigns and clinical intervention. E-cigarettes have disrupted that trajectory, introducing a new generation to #nicotine dependence. ➡️ Nicotine #vaping prevalence among adults ages 18-25 more than doubled from 11.7% in 2020 to 23.7% in 2024. ➡️ #Ecigarette or vaping product use-associated lung injury patient volume peaked in 2022 at 107.6% above the 2020 baseline before declining to 55.4% above the baseline in 2024. More in our latest study 🔗 https://lnkd.in/eG-MisKi

Nearly 80% of metropolitan health markets were highly concentrated for both inpatient care and commercial health insurance in 2024 – and there were not any competitive health insurance markets among the 384 CBSAs studied. While 76.8% of markets had matched concentration levels between providers and payers, suggesting a relative balance of market power, situations where that symmetry breaks down create the conditions for outsized rate-setting leverage and higher costs for patients and employers. Read the full study 🔗 https://lnkd.in/eehwtD-f

A recent New York Times opinion piece argued that hospital monopolies are the primary driver of rising #healthcarecosts, not insurance companies, and that price controls are the solution. But the data tells a more complicated story. Even in markets controlled by a single system, the average operating margin is -1.7%, and 1,547 hospitals are already in the red. If concentration were driving price gouging, we'd expect #monopoly hospitals to show meaningfully better margins than competitive ones, but we do not see this. Some will argue negative margins just mean hospitals have high costs, not that they're pricing fairly. But that cuts both ways. If monopoly hospitals are already losing money, #pricecaps are more likely to accelerate closures in the communities that can least afford to lose them than to bring costs down. The thought that the hospital lobby is materially outspending – or outperforming – the #healthinsurance lobby is a curious one (see #AffordableCareAct ). In fact, both are outspent 4x by life sciences. If we want to know who's really protecting the status quo, the data points elsewhere. 

Exact agreement between hospital and health plan price transparency data is the exception rather than the rule, with rate discrepancies observed across payers and procedure codes, even in a very small sample size. Across inpatient MS-DRGs, exact rate matches occurred in only 9.0% of hospital-payer-procedure combinations, and fewer than half fell within 10%. Said differently, there was more than a 10% difference between the HPPT rate and the hospital rate for more than 80% of the MS-DRGs. More in our latest study 🔗 https://lnkd.in/eqY3-GRM

The U.S. health economy has long acknowledged the behavioral health crisis. Acknowledgment is not sufficient. More in our 2026 Behavioral Health Report 🔗 https://lnkd.in/edPg_3Sw #behavioralhealth #mentalhealth

The #2026Match data reflect a physician workforce pipeline that is growing in volume but not at a rate commensurate with demand and clinical need. The specialties with the greatest growth in positions offered from 2022 to 2026: Vascular surgery: 31.0% Neurology: 23.6% Psychiatry: 22.9% Internal medicine: 17.9% Despite this growth, these specialities are still projected to face supply shortfalls by 2038, with the exception of #neurology. This pattern suggests that residency expansion is being driven as much by economic incentives and trainee lifestyle preferences as by population health need. Read the full study 🔗 https://lnkd.in/e9ncHgan #Psychiatry #Internalmedicine #Vascularsurgery

While many health economy stakeholders know the mantra that "healthcare is local," few fully understand the factors that drive that variation. Population demographics – including age, sex, income, education and ethnicity – are among the most influential and dynamic factors that shape demand for healthcare. A patient’s demographic characteristics impact their care-seeking behaviors, ability to pay, care delivery preferences, health-related needs and trust in the healthcare system. As a result, #demographic factors are a foundational input to evidence-based strategy. Learn how demographics influence the health economy 🔗 https://lnkd.in/eU9-tKtD

In a recent conversation with Fierce Healthcare, our Chief Research Officer, Allison Oakes, Ph.D., shares key findings from our 2026 Behavioral Health Report, including rising utilization, shifting prescription volumes and what it will take for the industry to move from acknowledgment to action. Read the full article 🔗 https://lnkd.in/e7n5bZgA #behavioralhealth #mentalhealth